Epidemiology of Nontuberculous Mycobacterial infections and associated chronic Macrolide use among persons with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 7, 2013, Pages 807-812

  Binder, Alison M ^a   Adjemian, Jennifer ^a   Olivier, Kenneth N ^b   Rebecca Prevots, D ^a  

^a Epidemiol   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cystic fibrosis; Macrolides; Nontuberculous mycobacteria

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INCIDENCE; INFECTIONS NONTUBERCULOUS MYCOBACTERIAL; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SPECIES DIFFERENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; REGISTRIES; YOUNG ADULT;

EID: 84885183409     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1200OC     Document Type: Article

References (23)

1. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834.
2. Olivier KN. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr Respir Rev 2004;5(Suppl A):S213-S216.
3. Hjelte L, Petrini B, Källenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990; 45:397-400. (Pubitemid 20184900)
4. Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet M.A., Le Roux E, Lemonnier L, et al.; OM.A. Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 2009;47: 4124-4128.
5. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, et al. Multicenter crosssectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008;14:378-384. (Pubitemid 351451383)
6. Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, Fauroux B, Mariani P, Munck A, Bingen E, et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005;43:3467-3470. (Pubitemid 40981368)
7. Esther CR Jr, Henry MM, Molina PL, Leigh MW. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005;40:39-44. (Pubitemid 40917906)
8. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco M.F., et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDS.A. statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
9. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902.
10. Bange FC, Kirschner P, Böttger EC. Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol 1999;37:3761-3763. (Pubitemid 29491136)
11. Cystic Fibrosis Trust. Antibiotic treatment for cystic fibrosis. Report of the UK Cystic Fibrosis Trust Antibiotic Group. Bromley, UK: UK Cystic Fibrosis Trust; 2009.
12. Sanguinetti M, Ardito F, Fiscarelli E, La Sorda M, D'Argenio P, Ricciotti G, Fadda G. Fatal pulmonary infection due to multidrugresistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001;39:816-819. (Pubitemid 32150872)
13. Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP, Paradowski LJ, Aris RM. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006;61:507-513. (Pubitemid 43901521)
14. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 2011;121:3554-3563.
15. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-S14.
16. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254. (Pubitemid 23201140)
17. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995;29:777-807. (Pubitemid 26005359)
18. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003; 52:1159-1164. (Pubitemid 36877429)
19. Equi A, Balfour-Lynn IM, Bush A, RosenthalM. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360:978-984. (Pubitemid 35284109)
20. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004;17:57-71. (Pubitemid 38120929)
21. Catherinot E, Roux AL, Vibet M.A., Bellis G, Lemonnier L, Le Roux E, Bernede-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, et al. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients. Eur Respir J 2013;41:1101-1106.
22. Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, Lee K, Lee SH, Daley CL, Kim S, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med 2012;186:917-925.
23. Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;174:928-934. (Pubitemid 44564794)